NAKI Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3M

  • Investors
  • 2

NAKI Therapeutics General Information

Description

Operator of a research-focused biopharmaceutical company intended to kill cancer cells effectively and safely compared to existing treatments. The company's therapy re-engineers cells that belong to the human innate immune system to target a specific cancer cell surface marker, enabling healthcare workers to provide effective cancer treatment.

Contact Information

Website
www.nakitherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 556 Morris Avenue
  • S7 F3
  • Summit, NJ 07901
  • United States
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 556 Morris Avenue
  • S7 F3
  • Summit, NJ 07901
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NAKI Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Oct-2021 $3M Completed Generating Revenue
To view NAKI Therapeutics’s complete valuation and funding history, request access »

NAKI Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view NAKI Therapeutics’s complete cap table history, request access »

NAKI Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NAKI Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Changrong Capital Venture Capital Minority
Westfield BioVentures Accelerator/Incubator Minority
To view NAKI Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

NAKI Therapeutics FAQs

  • When was NAKI Therapeutics founded?

    NAKI Therapeutics was founded in 2020.

  • Where is NAKI Therapeutics headquartered?

    NAKI Therapeutics is headquartered in Summit, NJ.

  • What is the size of NAKI Therapeutics?

    NAKI Therapeutics has 4 total employees.

  • What industry is NAKI Therapeutics in?

    NAKI Therapeutics’s primary industry is Biotechnology.

  • Is NAKI Therapeutics a private or public company?

    NAKI Therapeutics is a Private company.

  • What is the current valuation of NAKI Therapeutics?

    The current valuation of NAKI Therapeutics is .

  • What is NAKI Therapeutics’s current revenue?

    The current revenue for NAKI Therapeutics is .

  • How much funding has NAKI Therapeutics raised over time?

    NAKI Therapeutics has raised $3M.

  • Who are NAKI Therapeutics’s investors?

    Changrong Capital and Westfield BioVentures have invested in NAKI Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process